The novel strategy for treatment of patients with colorectal liver metastases by multi-disciplinary team

Weijun WANG,Zhiqian HU
2015-01-01
Abstract:Colorectal cancer is one of the most common malignant tumors of digestive tract.The liver is a frequent site of metastatic colorectal disease. Only less than 20% of colorectal liver metastases (CRLM ) can be surgically resected, so that the liver metastases is one of the important causes of death in patients withCRLM. For this reason, a lot of the “guidelines for diagnosis and treatment” and “criterion” for CRLM were formulated at home and abroad. Because of the uneven medical levels in various hospitals of China, it is dififcult to completely follow the “guidelines” and “criterion” in treatment of CRLM. Therefore, this article summarizes therapeutic measures suitable for majority of doctors in treatment of CRLM including surgery, neoadjuvant chemotherapy and adjuvant chemotherapy, local treatment and multi-disciplinary treatment.
What problem does this paper attempt to address?